Robert Hyde, based in Risch-Rotkreuz, ZG, CH, is currently a Co-Founder International Registry for Alzheimer’s Disease and other Dementias (InRAD) at InRAD – International, practice-based registry for Alzheimer's Disease and other. Robert Hyde brings experience from previous roles at GWS GmbH, Biogen and Biogen International GmbH. Robert Hyde holds a 1985 - 1988 PhD in Drug Targeting with phagocytic cells @ Aston University. With a robust skill set that includes Biotechnology, Medical Affairs, Pharmaceutical Industry, Neurology, Clinical Development and more. Robert Hyde has 2 emails on RocketReach.
Looking for a different Robert Hyde?
Find contact details for 700 million professionals.